Medicine prices in China are falling and profits of pharmaceuticals companies are under pressure as Beijing implements a revolution in drug costs and healthcare finance — but analysts warn that reforms will leave big holes in hospital budgets.
随着manbetx3.0 政府在药费支出和医疗财政方面进行革命性改革，manbetx3.0 的药品价格正在下降，制药企业的利润也面临压力。但分析师警告称，这些改革将使各个医院的预算产生较大的缺口。
您已阅读7%（323字），剩余93%（4627字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。